{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:30:37Z","timestamp":1792690237368,"version":"4.5.0"},"reference-count":54,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"23","license":[{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,6]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>\n                      In the past decade, next-generation sequencing has spurred significant progress in the understanding of cytogenetic alterations that occur in meningiomas. Eighty percent of adult meningiomas harbor pathogenic somatic variants involving\n                      <jats:italic>NF2<\/jats:italic>\n                      ,\n                      <jats:italic>TRAF7<\/jats:italic>\n                      ,\n                      <jats:italic>SMARCB1<\/jats:italic>\n                      ,\n                      <jats:italic>KLF4<\/jats:italic>\n                      ,\n                      <jats:italic>PI3K<\/jats:italic>\n                      , or\n                      <jats:italic>POLR2A.<\/jats:italic>\n                      Somatic variants in\n                      <jats:italic>TRAF7<\/jats:italic>\n                      associated with meningiomas usually localize to the gene\u2019s WD40 domains but are mutually exclusive to germline mutations, which cause a distinctive autosomal dominant syndrome.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBSERVATIONS<\/jats:title>\n                    <jats:p>\n                      This case involved a 15-year-old girl with bilateral optic nerve sheath meningiomas, diffuse meningiomatosis, and syndromic features, including craniosynostosis, brain anomalies, syndactyly, brachydactyly, epicanthus, and patent ductus arteriosus. Genetic testing of the meningioma specimen 7 years after biopsy showed a pathogenic p.R641C variant within the WD40 domain of the\n                      <jats:italic>TRAF7<\/jats:italic>\n                      gene. Additional testing of unaffected tissues identified the same variant at lower allele frequencies, consistent with postzygotic somatic mosaicism.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LESSONS<\/jats:title>\n                    <jats:p>\n                      The authors report postzygotic somatic mosaicism for a p.R641C variant in the\n                      <jats:italic>TRAF7<\/jats:italic>\n                      gene in a patient with bilateral optic nerve sheath meningiomas, diffuse meningiomatosis and a constellation of systemic findings previously recognized in patients with germline mutations of this gene. This is the first report of optic nerve sheath meningioma in a patient with mutation in the\n                      <jats:italic>TRAF7<\/jats:italic>\n                      gene.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/case2247","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T03:51:49Z","timestamp":1655092309000},"source":"Crossref","is-referenced-by-count":3,"title":["TRAF7 somatic mosaicism in a patient with bilateral optic nerve sheath meningiomas: illustrative case"],"prefix":"10.3171","volume":"3","author":[{"given":"Georgia","family":"Kaidonis","sequence":"first","affiliation":[{"name":"Departments of Ophthalmology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melike","family":"Pekmezci","sequence":"additional","affiliation":[{"name":"Departments of Ophthalmology"},{"name":"Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Van Ziffle","sequence":"additional","affiliation":[{"name":"Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurtis I.","family":"Auguste","sequence":"additional","affiliation":[{"name":"Neurosurgery, University of California, San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C.","family":"Horton","sequence":"additional","affiliation":[{"name":"Departments of Ophthalmology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"5110","key":"b1","series-title":"Nature","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/216084a0","article-title":"Chromosomal constitution of meningiomas","volume":"216","author":"Zang KD","year":"1967","unstructured":"Zang KD, Singer H. Chromosomal constitution of meningiomas. Nature. 1967;216(5110):84\u201385.10.1038\/216084a0"},{"issue":"4","key":"b2","series-title":"Cancer Genet Cytogenet","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0165-4608(80)90044-8","article-title":"Correlations between clinical and cytogenetical data in 180 human meningiomas","volume":"1","author":"Zankl H","year":"1980","unstructured":"Zankl H, Zang KD. Correlations between clinical and cytogenetical data in 180 human meningiomas. Cancer Genet Cytogenet. 1980;1(4):351\u2013356.10.1016\/0165-4608(80)90044-8"},{"issue":"18","key":"b3","series-title":"Cancer Res","first-page":"5863","article-title":"Molecular genetic analysis of chromosome 22 in 81 cases of meningioma","volume":"50","author":"Dumanski JP","year":"1990","unstructured":"Dumanski JP, Rouleau GA, Nordenskj\u00f6ld M, Collins VP. Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. Cancer Res. 1990;50(18):5863\u20135867.2393856"},{"issue":"6429","key":"b4","series-title":"Nature","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2","volume":"363","author":"Rouleau GA","year":"1993","unstructured":"Rouleau GA, Merel P, Lutchman M,  Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature. 1993;363(6429):515\u2013521.10.1038\/363515a0"},{"issue":"3","key":"b5","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11060-010-0339-x","article-title":"Meningiomas and neurofibromatosis","volume":"99","author":"Goutagny S","year":"2010","unstructured":"Goutagny S, Kalamarides M. Meningiomas and neurofibromatosis. J Neurooncol. 2010;99(3):341\u2013347.2071478210.1007\/s11060-010-0339-x"},{"issue":"4","key":"b6","series-title":"Brain Tumor Pathol","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10014-016-0271-7","article-title":"Genetic landscape of meningioma","volume":"33","author":"Yuzawa S","year":"2016","unstructured":"Yuzawa S, Nishihara H, Tanaka S. Genetic landscape of meningioma. Brain Tumor Pathol. 2016;33(4):237\u2013247.2762447010.1007\/s10014-016-0271-7"},{"key":"b7","series-title":"J Neurosurg","article-title":"Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas","author":"Youngblood MW","unstructured":"Youngblood MW, Duran D, Montejo JD,  Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas. J Neurosurg. Published online October 25, 2019. doi:10.3171\/2019.8.JNS191266."},{"issue":"6123","key":"b8","series-title":"Science","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark VE","year":"2013","unstructured":"Clark VE, Erson-Omay EZ, Serin A,  Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science. 2013;339(6123):1077\u20131080.2334850510.1126\/science.1233009"},{"issue":"5","key":"b9","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/neuonc\/nov316","article-title":"Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma","volume":"18","author":"Abedalthagafi M","year":"2016","unstructured":"Abedalthagafi M, Bi WL, Aizer AA,  Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro Oncol. 2016;18(5):649\u2013655.2682620110.1093\/neuonc\/nov316"},{"issue":"7","key":"b10","series-title":"Mod Pathol","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/modpathol.2016.81","article-title":"Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system","volume":"29","author":"Yuzawa S","year":"2016","unstructured":"Yuzawa S, Nishihara H, Yamaguchi S,  Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system. Mod Pathol. 2016;29(7):708\u2013716.2710234410.1038\/modpathol.2016.81"},{"issue":"6","key":"b11","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/neuros\/nyy121","article-title":"Familial syndromes involving meningiomas provide mechanistic insight into sporadic disease","volume":"83","author":"Kerr K","year":"2018","unstructured":"Kerr K, Qualmann K, Esquenazi Y, Hagan J, Kim DH. Familial syndromes involving meningiomas provide mechanistic insight into sporadic disease. Neurosurgery. 2018;83(6):1107\u20131118.2966002610.1093\/neuros\/nyy121"},{"issue":"7","key":"b12","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1212\/WNL.43.7.1436","article-title":"Association between meningioma and Cowden\u2019s disease","volume":"43","author":"Lyons CJ","year":"1993","unstructured":"Lyons CJ, Wilson CB, Horton JC. Association between meningioma and Cowden\u2019s disease. Neurology. 1993;43(7):1436\u20131437.832715410.1212\/WNL.43.7.1436"},{"issue":"11","key":"b13","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1212\/WNL.56.11.1433","article-title":"The clinical and diagnostic implications of mosaicism in the neurofibromatoses","volume":"56","author":"Ruggieri M","year":"2001","unstructured":"Ruggieri M, Huson SM. The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology. 2001;56(11):1433\u20131443.1140941310.1212\/WNL.56.11.1433"},{"issue":"5","key":"b14","series-title":"Neuro Oncol","first-page":"699","article-title":"Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy","volume":"19","author":"Kline CN","year":"2017","unstructured":"Kline CN, Joseph NM, Grenert JP,  Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro Oncol. 2017;19(5):699\u2013709.28453743"},{"issue":"5","key":"b15","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/neuonc\/noaa226","article-title":"Associations of meningioma molecular subgroup and tumor recurrence","volume":"23","author":"Youngblood MW","year":"2021","unstructured":"Youngblood MW, Miyagishima DF, Jin L,  Associations of meningioma molecular subgroup and tumor recurrence. Neuro Oncol. 2021;23(5):783\u2013794.3306842110.1093\/neuonc\/noaa226"},{"issue":"6","key":"b16","series-title":"J Cell Physiol","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/jcp.25676","article-title":"The emerging role of TRAF7 in tumor development","volume":"232","author":"Zotti T","year":"2017","unstructured":"Zotti T, Scudiero I, Vito P, Stilo R. The emerging role of TRAF7 in tumor development. J Cell Physiol. 2017;232(6):1233\u20131238.2780842310.1002\/jcp.25676"},{"issue":"4","key":"b17","series-title":"Nat Genet","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno R","year":"2016","unstructured":"Bueno R, Stawiski EW, Goldstein LD,  Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat Genet. 2016;48(4):407\u2013416.2692822710.1038\/ng.3520"},{"issue":"3","key":"b18","series-title":"J Cell Physiol","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/jcp.24011","article-title":"The seventh ring: exploring TRAF7 functions","volume":"227","author":"Zotti T","year":"2012","unstructured":"Zotti T, Vito P, Stilo R. The seventh ring: exploring TRAF7 functions. J Cell Physiol. 2012;227(3):1280\u20131284.2210576710.1002\/jcp.24011"},{"issue":"1","key":"b19","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11060-019-03198-9","article-title":"Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas","volume":"144","author":"Hao S","year":"2019","unstructured":"Hao S, Huang G, Feng J,  Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas. J Neurooncol. 2019;144(1):11\u201320.3117742510.1007\/s11060-019-03198-9"},{"issue":"1","key":"b20","series-title":"Am J Hum Genet","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ajhg.2018.06.005","article-title":"De novo missense variants in TRAF7 cause developmental delay, congenital anomalies, and dysmorphic features","volume":"103","author":"Tokita MJ","year":"2018","unstructured":"Tokita MJ, Chen CA, Chitayat D,  De novo missense variants in TRAF7 cause developmental delay, congenital anomalies, and dysmorphic features. Am J Hum Genet. 2018;103(1):154\u2013162.2996156910.1016\/j.ajhg.2018.06.005"},{"issue":"7","key":"b21","series-title":"Genet Med","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/s41436-020-0792-7","article-title":"Phenotypic spectrum and transcriptomic profile associated with germline variants in TRAF7","volume":"22","author":"Castilla-Vallmanya L","year":"2020","unstructured":"Castilla-Vallmanya L, Selmer KK, Dimartino C,  Phenotypic spectrum and transcriptomic profile associated with germline variants in TRAF7. Genet Med. 2020;22(7):1215\u20131226.3237698010.1038\/s41436-020-0792-7"},{"issue":"44","key":"b22","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"17115","DOI":"10.1073\/pnas.0805239105","article-title":"Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development","volume":"105","author":"Newbern J","year":"2008","unstructured":"Newbern J, Zhong J, Wickramasinghe RS,  Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development. Proc Natl Acad Sci U S A. 2008;105(44):17115\u201317120.1895284710.1073\/pnas.0805239105"},{"issue":"1","key":"b23","series-title":"Neuropathology","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/neup.12426","article-title":"Clinicopathological and molecular characteristics of pediatric meningiomas","volume":"38","author":"Battu S","year":"2018","unstructured":"Battu S, Kumar A, Pathak P,  Clinicopathological and molecular characteristics of pediatric meningiomas. Neuropathology. 2018;38(1):22\u201333.2890166610.1111\/neup.12426"},{"issue":"6","key":"b24","series-title":"Brain Pathol","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/bpa.12884","article-title":"Pediatric meningioma: a clinicopathologic and molecular study with potential grading implications","volume":"30","author":"Toland A","year":"2020","unstructured":"Toland A, McNulty SN, Pekmezci M,  Pediatric meningioma: a clinicopathologic and molecular study with potential grading implications. Brain Pathol. 2020;30(6):1134\u20131143.3271656810.1111\/bpa.12884"},{"issue":"5","key":"b25","series-title":"Neuropediatrics","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1055\/s-0034-1372303","article-title":"Unexplained loss of vision in a child: consider bilateral primary optic nerve sheath meningioma","volume":"45","author":"Nickel M","year":"2014","unstructured":"Nickel M, L\u00f6bel U, Holst B,  Unexplained loss of vision in a child: consider bilateral primary optic nerve sheath meningioma. Neuropediatrics. 2014;45(5):321\u2013324.10.1055\/s-0034-1372303"},{"key":"b26","series-title":"Eye Brain","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2147\/EB.S144345","article-title":"Optic nerve sheath meningiomas: prevalence, impact, and management strategies","volume":"10","author":"Parker RT","year":"2018","unstructured":"Parker RT, Ovens CA, Fraser CL, Samarawickrama C. Optic nerve sheath meningiomas: prevalence, impact, and management strategies. Eye Brain. 2018;10:85\u201399.3049838510.2147\/EB.S144345"},{"issue":"2","key":"b27","series-title":"Brain Pathol","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/bpa.12150","article-title":"Genetic profiling by single-nucleotide polymorphism-based array analysis defines three distinct subtypes of orbital meningioma","volume":"25","author":"Ho CY","year":"2015","unstructured":"Ho CY, Mosier S, Safneck J,  Genetic profiling by single-nucleotide polymorphism-based array analysis defines three distinct subtypes of orbital meningioma. Brain Pathol. 2015;25(2):193\u2013201.2477324610.1111\/bpa.12150"},{"issue":"5110","key":"b1","series-title":"Nature","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/216084a0","article-title":"Chromosomal constitution of meningiomas","volume":"216","author":"Zang KD","year":"1967","unstructured":"Zang KD, Singer H. Chromosomal constitution of meningiomas. Nature. 1967;216(5110):84\u201385.10.1038\/216084a0"},{"issue":"4","key":"b2","series-title":"Cancer Genet Cytogenet","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0165-4608(80)90044-8","article-title":"Correlations between clinical and cytogenetical data in 180 human meningiomas","volume":"1","author":"Zankl H","year":"1980","unstructured":"Zankl H, Zang KD. Correlations between clinical and cytogenetical data in 180 human meningiomas. Cancer Genet Cytogenet. 1980;1(4):351\u2013356.10.1016\/0165-4608(80)90044-8"},{"issue":"18","key":"b3","series-title":"Cancer Res","first-page":"5863","article-title":"Molecular genetic analysis of chromosome 22 in 81 cases of meningioma","volume":"50","author":"Dumanski JP","year":"1990","unstructured":"Dumanski JP, Rouleau GA, Nordenskj\u00f6ld M, Collins VP. Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. Cancer Res. 1990;50(18):5863\u20135867.2393856"},{"issue":"6429","key":"b4","series-title":"Nature","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2","volume":"363","author":"Rouleau GA","year":"1993","unstructured":"Rouleau GA, Merel P, Lutchman M,  Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature. 1993;363(6429):515\u2013521.10.1038\/363515a0"},{"issue":"3","key":"b5","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11060-010-0339-x","article-title":"Meningiomas and neurofibromatosis","volume":"99","author":"Goutagny S","year":"2010","unstructured":"Goutagny S, Kalamarides M. Meningiomas and neurofibromatosis. J Neurooncol. 2010;99(3):341\u2013347.2071478210.1007\/s11060-010-0339-x"},{"issue":"4","key":"b6","series-title":"Brain Tumor Pathol","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10014-016-0271-7","article-title":"Genetic landscape of meningioma","volume":"33","author":"Yuzawa S","year":"2016","unstructured":"Yuzawa S, Nishihara H, Tanaka S. Genetic landscape of meningioma. Brain Tumor Pathol. 2016;33(4):237\u2013247.2762447010.1007\/s10014-016-0271-7"},{"key":"b7","series-title":"J Neurosurg","article-title":"Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas","author":"Youngblood MW","unstructured":"Youngblood MW, Duran D, Montejo JD,  Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas. J Neurosurg. Published online October 25, 2019. doi:10.3171\/2019.8.JNS191266."},{"issue":"6123","key":"b8","series-title":"Science","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark VE","year":"2013","unstructured":"Clark VE, Erson-Omay EZ, Serin A,  Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science. 2013;339(6123):1077\u20131080.2334850510.1126\/science.1233009"},{"issue":"5","key":"b9","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/neuonc\/nov316","article-title":"Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma","volume":"18","author":"Abedalthagafi M","year":"2016","unstructured":"Abedalthagafi M, Bi WL, Aizer AA,  Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro Oncol. 2016;18(5):649\u2013655.2682620110.1093\/neuonc\/nov316"},{"issue":"7","key":"b10","series-title":"Mod Pathol","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/modpathol.2016.81","article-title":"Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system","volume":"29","author":"Yuzawa S","year":"2016","unstructured":"Yuzawa S, Nishihara H, Yamaguchi S,  Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system. Mod Pathol. 2016;29(7):708\u2013716.2710234410.1038\/modpathol.2016.81"},{"issue":"6","key":"b11","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/neuros\/nyy121","article-title":"Familial syndromes involving meningiomas provide mechanistic insight into sporadic disease","volume":"83","author":"Kerr K","year":"2018","unstructured":"Kerr K, Qualmann K, Esquenazi Y, Hagan J, Kim DH. Familial syndromes involving meningiomas provide mechanistic insight into sporadic disease. Neurosurgery. 2018;83(6):1107\u20131118.2966002610.1093\/neuros\/nyy121"},{"issue":"7","key":"b12","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1212\/WNL.43.7.1436","article-title":"Association between meningioma and Cowden\u2019s disease","volume":"43","author":"Lyons CJ","year":"1993","unstructured":"Lyons CJ, Wilson CB, Horton JC. Association between meningioma and Cowden\u2019s disease. Neurology. 1993;43(7):1436\u20131437.832715410.1212\/WNL.43.7.1436"},{"issue":"11","key":"b13","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1212\/WNL.56.11.1433","article-title":"The clinical and diagnostic implications of mosaicism in the neurofibromatoses","volume":"56","author":"Ruggieri M","year":"2001","unstructured":"Ruggieri M, Huson SM. The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology. 2001;56(11):1433\u20131443.1140941310.1212\/WNL.56.11.1433"},{"issue":"5","key":"b14","series-title":"Neuro Oncol","first-page":"699","article-title":"Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy","volume":"19","author":"Kline CN","year":"2017","unstructured":"Kline CN, Joseph NM, Grenert JP,  Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro Oncol. 2017;19(5):699\u2013709.28453743"},{"issue":"5","key":"b15","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/neuonc\/noaa226","article-title":"Associations of meningioma molecular subgroup and tumor recurrence","volume":"23","author":"Youngblood MW","year":"2021","unstructured":"Youngblood MW, Miyagishima DF, Jin L,  Associations of meningioma molecular subgroup and tumor recurrence. Neuro Oncol. 2021;23(5):783\u2013794.3306842110.1093\/neuonc\/noaa226"},{"issue":"6","key":"b16","series-title":"J Cell Physiol","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/jcp.25676","article-title":"The emerging role of TRAF7 in tumor development","volume":"232","author":"Zotti T","year":"2017","unstructured":"Zotti T, Scudiero I, Vito P, Stilo R. The emerging role of TRAF7 in tumor development. J Cell Physiol. 2017;232(6):1233\u20131238.2780842310.1002\/jcp.25676"},{"issue":"4","key":"b17","series-title":"Nat Genet","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno R","year":"2016","unstructured":"Bueno R, Stawiski EW, Goldstein LD,  Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat Genet. 2016;48(4):407\u2013416.2692822710.1038\/ng.3520"},{"issue":"3","key":"b18","series-title":"J Cell Physiol","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/jcp.24011","article-title":"The seventh ring: exploring TRAF7 functions","volume":"227","author":"Zotti T","year":"2012","unstructured":"Zotti T, Vito P, Stilo R. The seventh ring: exploring TRAF7 functions. J Cell Physiol. 2012;227(3):1280\u20131284.2210576710.1002\/jcp.24011"},{"issue":"1","key":"b19","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11060-019-03198-9","article-title":"Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas","volume":"144","author":"Hao S","year":"2019","unstructured":"Hao S, Huang G, Feng J,  Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas. J Neurooncol. 2019;144(1):11\u201320.3117742510.1007\/s11060-019-03198-9"},{"issue":"1","key":"b20","series-title":"Am J Hum Genet","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ajhg.2018.06.005","article-title":"De novo missense variants in TRAF7 cause developmental delay, congenital anomalies, and dysmorphic features","volume":"103","author":"Tokita MJ","year":"2018","unstructured":"Tokita MJ, Chen CA, Chitayat D,  De novo missense variants in TRAF7 cause developmental delay, congenital anomalies, and dysmorphic features. Am J Hum Genet. 2018;103(1):154\u2013162.2996156910.1016\/j.ajhg.2018.06.005"},{"issue":"7","key":"b21","series-title":"Genet Med","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/s41436-020-0792-7","article-title":"Phenotypic spectrum and transcriptomic profile associated with germline variants in TRAF7","volume":"22","author":"Castilla-Vallmanya L","year":"2020","unstructured":"Castilla-Vallmanya L, Selmer KK, Dimartino C,  Phenotypic spectrum and transcriptomic profile associated with germline variants in TRAF7. Genet Med. 2020;22(7):1215\u20131226.3237698010.1038\/s41436-020-0792-7"},{"issue":"44","key":"b22","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"17115","DOI":"10.1073\/pnas.0805239105","article-title":"Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development","volume":"105","author":"Newbern J","year":"2008","unstructured":"Newbern J, Zhong J, Wickramasinghe RS,  Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development. Proc Natl Acad Sci U S A. 2008;105(44):17115\u201317120.1895284710.1073\/pnas.0805239105"},{"issue":"1","key":"b23","series-title":"Neuropathology","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/neup.12426","article-title":"Clinicopathological and molecular characteristics of pediatric meningiomas","volume":"38","author":"Battu S","year":"2018","unstructured":"Battu S, Kumar A, Pathak P,  Clinicopathological and molecular characteristics of pediatric meningiomas. Neuropathology. 2018;38(1):22\u201333.2890166610.1111\/neup.12426"},{"issue":"6","key":"b24","series-title":"Brain Pathol","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/bpa.12884","article-title":"Pediatric meningioma: a clinicopathologic and molecular study with potential grading implications","volume":"30","author":"Toland A","year":"2020","unstructured":"Toland A, McNulty SN, Pekmezci M,  Pediatric meningioma: a clinicopathologic and molecular study with potential grading implications. Brain Pathol. 2020;30(6):1134\u20131143.3271656810.1111\/bpa.12884"},{"issue":"5","key":"b25","series-title":"Neuropediatrics","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1055\/s-0034-1372303","article-title":"Unexplained loss of vision in a child: consider bilateral primary optic nerve sheath meningioma","volume":"45","author":"Nickel M","year":"2014","unstructured":"Nickel M, L\u00f6bel U, Holst B,  Unexplained loss of vision in a child: consider bilateral primary optic nerve sheath meningioma. Neuropediatrics. 2014;45(5):321\u2013324.10.1055\/s-0034-1372303"},{"key":"b26","series-title":"Eye Brain","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2147\/EB.S144345","article-title":"Optic nerve sheath meningiomas: prevalence, impact, and management strategies","volume":"10","author":"Parker RT","year":"2018","unstructured":"Parker RT, Ovens CA, Fraser CL, Samarawickrama C. Optic nerve sheath meningiomas: prevalence, impact, and management strategies. Eye Brain. 2018;10:85\u201399.3049838510.2147\/EB.S144345"},{"issue":"2","key":"b27","series-title":"Brain Pathol","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/bpa.12150","article-title":"Genetic profiling by single-nucleotide polymorphism-based array analysis defines three distinct subtypes of orbital meningioma","volume":"25","author":"Ho CY","year":"2015","unstructured":"Ho CY, Mosier S, Safneck J,  Genetic profiling by single-nucleotide polymorphism-based array analysis defines three distinct subtypes of orbital meningioma. Brain Pathol. 2015;25(2):193\u2013201.2477324610.1111\/bpa.12150"}],"container-title":["Journal of Neurosurgery: Case Lessons"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-case-lessons\/3\/23\/article-CASE2247.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-case-lessons\/3\/23\/article-CASE2247.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-case-lessons\/3\/23\/article-CASE2247.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T14:44:30Z","timestamp":1770302670000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-case-lessons\/3\/23\/article-CASE2247.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,6]]},"references-count":54,"journal-issue":{"issue":"23"},"URL":"https:\/\/doi.org\/10.3171\/case2247","relation":{},"ISSN":["2694-1902"],"issn-type":[{"value":"2694-1902","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,6]]}}}